Sun Pharma Advanced Research CompanySPARC 
$2.690.20%24h
0.20%24h
Global rank8439
Market cap$766.36M
Change 7d0.04%
YTD Performance-21.58%
SP500 benchmarkUnderperform
P/E-0.34
P/S26.92
Revenue$28.47M
Earnings-$26.54M
Dividend yield-
Main Sector
Healthcare
Category
Sun Pharma Advanced Research Company SPARC Total Debt
SPARC Total Debt in 2022: $1.50M
According to Sun Pharma Advanced Research Company latest financial reports the total debt is $1.50M, an increase of 417.87% to 2022. At the end of 2022 company had $290.51K total debt. This figure represents the debts and financial obligations that Sun Pharma Advanced Research Company combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Sun Pharma Advanced Research Company SPARC Total Debt History from 2023 to 2022
-
Value:-
SPARC Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $1.50M | 417.87% |
| 2022 | $290.51K | -97.91% |
| 2021 | $13.91M | 1729.88% |
| 2020 | $760.38K | 484.90% |
| 2019 | $130.00K | - |
View the Top Total Debt Stocks 
